Fluoroquinolones and Drugs for UTI Flashcards
Fluoroquinolone Drugs
Ciprofloxacin Ofloxacin Levofloxacin Moxifloxacin Gatifloxacin Gemifloxacin "COLe Might Get Goals"
Fluoroquinolone MOA
Inhibition of DNA GYRASE (main target) - prevents relaxation of supercoiled DNA for transcription/replication
BACTERICIDAL
Fluoroquinolone Spectrum
Aerobic G- rods
Good G+ coverage
Exception: Moxifloxacin and Gemifloxacin are effective against ANAEROBES
Fluroquinolones effective against anaerobes
Moxifloxacin and Gemifloxacin
Only fluoroquinolones with “m” in the name
Ciprofloxacin Use
UTIs (2nd line, Bactrim is DOC), ANTHRAX prophylaxis, P. aeruginosa, systemic infections
Ofloxacin Use
PROSTATITIS, STDs (except syphilis), TB
Levofloxacin Use
CAP alternative (Macrolide is DOC)
CAP treatment
Macrolide (DOC) > Levofloxacin (or Gemifloxacin) > Telithromycin (has severe hepatotoxicity)
Moxifloxacin
PCN-resistant S. pneumoniae
ANAEROBES
Gatifloxacin
OCULAR application only
Gemifloxacin
PCN-resistant S. pneumonia
ANAEROBES
CAP alternative (Macrolide is DOC)
Fluoroquinolone Pharmacokinetics
Well absorbed ORALLY
Decreased absorption with CA, Mg, Al (antacids)
Widely distributed, EXCELLENT TISSUE PENETRATION
Poor CNS penetration
Excreted through kidney (can be blocked by probenecid)
Fluoroquinolone Adverse Effects
GI disturbances QT PROLONGATION Cartilage erosions Tendon rupture (more likely in men >50 w/ previous use of inhaled corticosteroids) Photosensitivity etc...
Fluoroquinolone Contraindication
Pregnant
Nursing
Children <18 years old (cartilage damage)
Fluoroquinolone Resistance
Plasmid mediated resistance:
Target site mutations (DNA gyrase/topoisomerase IV)
Reduced permeability
MDR efflux pump over-expression